Zika: surveillance, risk factors and vector management in Brazil

Lead Research Organisation: London School of Hygiene & Tropical Medicine
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Rapid developments in Zika virus surveillance, risk factor analysis and optimal control
strategy are immediately required to curtail the American outbreak. Since 2012, our Brazilian
partner has been leading an arbovirus serosurveillance cohort study of 117 pregnant women
and 278 infants in a favela of Manguinhos, Rio de Janeiro; and we will be piggybacking CI
Brasil's study for the currently proposed project. Half the requested funds will be transferred
to Brazil to support the PCR-confirmation of 181 suspected Zika cases among the cohort (in
addition to any suspected cases that arise over the next 18 months). PCR analysis will also
be conducted on mosquito samples collected from the households of febrile cases and their
neighbours. All collected mosquitoes of all species have been retained over the past 2 years
and stored appropriately for this follow-up analysis. This will allow for the incrimination of the
vector species that is/are primarily responsible for Zika transmission – a critical current
knowledge gap. Taking advantage of the years of collected data on the cohort
(socioeconomics, georeferenced locations, febrile history, mosquito numbers/species
collected, etc) coupled with the new diagnostic results, risk factor analysis will be conducted
using cutting-edge Model Based Geostatistical methods in order to produce the first Zika risk
maps for (primarily) Rio and (secondarily) Brazil. These data and risk factors will then inform
the construction of mathematical models developed to analyse optimal mosquito control
strategy employing both traditional tools (insecticides, breeding site elimination) and novel
approaches (sterile insect technique, genetic control and Wolbachia releases).

People

ORCID iD

 
Description Horizon 2020 consortium grant funded by the European Research Council (734584)
Amount € 12,000,000 (EUR)
Funding ID 734584 
Organisation European Research Council (ERC) 
Sector Public
Country Belgium
Start 10/2016 
End 09/2020
 
Description MRC LID PhD studentship
Amount £100,000 (GBP)
Organisation MRC Doctoral Training Program 
Sector Academic/University
Country United Kingdom
Start 10/2016 
End 03/2020
 
Title Metapopulation mathematical model of Zika in Latin and Central America 
Description Computer code detailing a metapopulation mathematical model of Zika in Latin and Central America 
Type Of Material Computer model/algorithm 
Year Produced 2016 
Provided To Others? Yes  
Impact This model was the first published field-validated mathematical model of Zika virus 
URL https://github.com/kath-o-reilly/Zika-LAC-Outbreaks/tree/master/Code
 
Title Zika case data for all Latin American Countries 
Description Zika reported case data for all Latin American Countries were collated by my research team 
Type Of Material Database/Collection of data 
Year Produced 2016 
Provided To Others? Yes  
Impact Country-level reports citing the data (and model outputs we produced using this data) were provided for all ministries of health for all Latin American and Central American countries 
URL https://github.com/kath-o-reilly/Zika-LAC-Outbreaks/tree/master/CountryReports
 
Description Patricia Brasil 
Organisation Oswaldo Cruz Foundation (Fiocruz)
Country Brazil 
Sector Public 
PI Contribution We are producing coupled entomological-epidemiological models based on mosquito data and clinical data collected from a slum area of Manguinhos in Rio de Janeiro. This collaborator has conducted all field collections already and the MRC'c contribution provided the means of testing the clinical samples in Fiocruz.
Collaborator Contribution This collaborator's team collected all entomological and epidemiological samples from the field site and have now tested the clinical samples for zika sero-positivity.
Impact Field data results have only recently been communicated and analysis (led by PI Yakob) is underway.
Start Year 2016